Oral Chinese patent medicines for herpangina in children: A network meta-analysis

Combining oral Chinese patent medicines with conventional treatment effectively shortens the time of fever and herpes in children. Additionally, no increase in adverse events was observed in terms of safety when oral Chinese patent medicines were combined with conventional treatment. This study has been registered in the International Prospective Register of Systematic Reviews (PROSPERO), with a registration number CRD42024503831.